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Abstract Amyloidogenic proteins undergo an alternative fold-
ing pathway under stressful conditions leading to formation of
¢brils having cross L-sheet structure, which is the hallmark of
many neurodegenerative diseases. As a means of surviving
against external stress, on the other hand, many microorganisms
accumulate small stress molecules to prevent abnormal protein
folding and to contribute to protein stability, which hints at the
e⁄cacy of the solutes against amyloid formation. The current
work demonstrates the e¡ectiveness of small stress molecules
such as ectoine, betaine, trehalose, and citrulline on inhibition
of insulin amyloid formation in vitro. The inhibitory e¡ects were
analyzed by thio£avin T-induced £uorescence, circular dichro-
ism, and atomic force microscopy. This report suggests that
naturally occurring small molecules may serve a function that
is typically ful¢lled by protein chaperones, and it provides a hint
for designing inhibitors against amyloid formation associated
with neurodegenerative disorders.
" 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
A number of structurally di¡erent proteins are now known
to form amyloid ¢brils when subjected to stress conditions
like high temperature and extreme pH [1^4]. These environ-
mental stresses trigger o¡ an alternative folding pathway for
amyloidogenic proteins, leading to partial unfolding of pro-
teins followed by formation of amyloid having cross L-sheet
structure [5,6]. The formation of amyloid aggregates and their
deposition in tissues is the pathological hallmark of many
neurodegenerative diseases such as Alzheimer’s and Parkin-
son’s disease, mad cow disease, and others [4,5]. While it is
still unresolved how normal and soluble proteins assemble
into ¢brillar and insoluble amyloid aggregates under certain
conditions [7], abnormal accumulation of amyloid oligomers,
proto¢brils, or ¢brils is considered to be one of the major
contributing factors to neurodegeneration [8^13]. Due to the
possible relation of amyloid to pathology, many e¡orts are
underway to screen compounds that interfere with amyloid
formation, and a few of those inhibitors are currently under-
going clinical trials as potential drugs to treat neurodegener-
ative disorders [4,10,11,14,15].
While environmental stress is a contributing factor in pro-
tein denaturation and aggregation [16,17], some life forms in
nature have successfully adapted to speci¢c types of stresses
[18,19]. For example, hyperthermophiles, which are microor-
ganisms capable of growing at temperatures as high as 113‡C,
accumulate unusual molecules called organic solutes or small
stress molecules as a means of surviving against thermal stress
[20^22]. Pyrococcus aerophilum (Topt = 100‡C) and Thermus
thermophilus (Topt = 70‡C) were reported to accumulate small
solutes such as trehalose and betaine in high concentrations
against heat stress [20,21]. Increasing evidence shows that
small stress molecules can contribute to thermostability of
enzymes, possessing the ability to maintain protein function-
ality under extreme environments by stabilizing the native
conformation of proteins [22^24]. Presence of small stress
molecules like ectoine, betaine, and trehalose had proved
highly e¡ective in preserving enzymatic activities against
heat treatment, freeze-thawing, and freeze-drying. For exam-
ple, these solutes elevated the temperatures at which 50% loss
of lactic dehydrogenase and phosphofructokinase activities
was observed up to 14‡C [25,26]. Citrulline is found in wild
watermelon leaves and acts as a free radical scavenger, con-
tributing to the high drought tolerance of the plant [27].
Those works show the protective nature of small stress mol-
ecules for maintaining protein stability and activity suggesting
the e⁄cacy of the stress molecules against amyloid formation,
which has been rarely studied so far.
In the present work, we report that the small stress mole-
cules strongly inhibit amyloid formation of insulin in vitro.
Insulin amyloid formation, a characteristic of injection-local-
ized amyloidosis, occurs through nucleation, elongation, and
saturation stages like other amyloidogenic proteins, and its
rate is highly accelerated under stressful conditions such as
high temperature, extreme pH, and high shear stress [28^32].
Our ¢nding can be useful for designing inhibitors that work
against amyloid formation.
2. Materials and methods
2.1. In vitro insulin amyloid formation
All chemicals and reagents were purchased from Sigma-Aldrich (St.
Louis, MO, USA). Stock solution of bovine insulin was made at 2 mg/
ml in glycine bu¡er (pH 2, 20 mM). It was then diluted with glycine
bu¡er to 1 mg/ml for control experiments and with solutions contain-
ing stress molecules in glycine bu¡er for inhibition studies. Incubation
was done in sealed glass vials (1.8 ml) to prevent any possible evap-
oration during incubation. In our preliminary experiments, insulin
solution was incubated at 37‡C, 44‡C, and 50‡C to observe the e¡ect
of heat stress on amyloid formation. Application of heat stress short-
ened the lag time for insulin amyloid formation and increased the
maximal value of thio£avin T (ThT) £uorescence at stationary phase.
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In this work, 50‡C was selected as the incubation temperature for
control experiments, where lag time and apparent rate constant
(kapp) were 12.3 h and 2.47 h31, respectively. For observing the e¡ect
of preformed nuclei, seed solution was made by incubating 1 mg/ml
insulin solution (pH 2, 20 mM) at 50‡C for 18 h. This pre-incubated
solution was added to freshly prepared 1 mg/ml insulin solution (pH
2, 20 mM) to make 1% of total solution volume.
2.2. ThT £uorescence measurement
ThT solution (50 WM, 1.5 ml) was mixed with 5 Wl samples in a
quartz cuvette. All £uorescence measurements were carried out with a
spectro£uorophotometer (Model RF5301, Shimadzu, Japan) accord-
ing to [33]. The excitation wavelength was set at 450 nm with emission
measured at 482 nm with excitation and emission slit widths at 5 nm
each. Each reading was done in triplicate and the average was used
for data analysis.
2.3. Circular dichroism (CD) measurement
The samples (20 Wl) were dialyzed before CD spectrum measure-
ment to avoid possible interference with stress molecules. Samples
were placed in mini-dialysis units from Fisher Scienti¢c (Rockford,
IL, USA), suspended in glycine bu¡er (pH 2, 20 mM), and left for
12 h. The resultant volume was then diluted to 300 Wl in a cell with a
0.1 mm path length for use in CD spectrum measurement. Interfer-
ence with ectoine and citrulline could not be removed even with the
dialysis treatment. CD spectra were measured on a spectropolarimeter
(Model J-710, Jasco, Japan) from 190 nm to 260 nm at a scan speed
of 50 nm/min and a resolution of 0.5 nm according to Bouchard et al.
[29].
2.4. Atomic force microscopy (AFM)
AFM was used to visualize amyloid ¢brils as per the method de-
scribed by Stine et al. [34]. An aliquot of 5 Wl from the incubated
solution was placed on freshly cleaved mica at room temperature for a
few seconds. Samples were diluted twice with 50 Wl of deionized water
followed by drying with nitrogen gas. AFM tips were used at a res-
onant frequency of 306^444 kHz for imaging ¢brils with a Nanoprobe
III scanning probe workstation (Digital Instruments, CA, USA). Each
image was acquired in tapping mode under ambient conditions at a
scan frequency of 1^2 Hz. Two di¡erent samples were analyzed in
each case and at least ¢ve spots with an area of 2U2 Wm were
scanned. The samples were used without dilution to maintain the
same concentration of ¢brils as present in the originally incubated
volume. Representative images were selected for comparative studies.
2.5. Evaluation of amyloid formation kinetics
The growth of amyloid structure, as depicted by the increase in ThT
£uorescence, followed a typical sigmoidal curve, having an initial lag
phase with no increase of £uorescence, followed by elongation and
then the saturation phase. The £uorescence data obtained were ¢tted
with a four-parameter sigmoidal curve using Sigma Plot v. 8.02
(SSPS, Chicago, IL, USA) as per the following equation:
y ¼ yo þ a
1þ e3
x3xo
b
 
where y is the £uorescence at time x, yo is the initial £uorescence
value, xo is the time when £uorescence reaches 50% of its maximum
value, and a is the maximal £uorescence at stationary phase. Kinetic
constants were calculated as apparent rate constant (kapp = 1/b) and
lag time (xo32b).
3. Results and discussion
Ectoine, trehalose, and citrulline completely suppressed in-
sulin amyloid formation at 300 mM as indicated by absence
of ThT £uorescence even after 40 h of incubation (Fig. 1).
Betaine also showed an inhibitory e¡ect at 300 mM, reducing
stationary ThT £uorescence to one third of the control value.
In contrast, maltose and sucrose, which are disaccharides hav-
ing structures similar to that of trehalose, did not suppress
amyloid formation at the same concentration (data not
shown). According to AFM images, the control sample con-
tained a high density of typical unbranched, insulin amyloid
¢brils (Fig. 2A), while ¢brils were rarely found in the samples
with trehalose (Fig. 2C), betaine (Fig. 2D), ectoine (Fig. 2E),
and citrulline (Fig. 2F). However, high ¢bril densities were
observed in the presence of maltose, which indicates a lack
of inhibitor action (Fig. 2B). Small stress molecules were
found to have inhibitory e¡ects at lower concentrations as
listed in Table 1. The apparent rate constants for all incuba-
tions in the presence of stress molecules were found to be
signi¢cantly lower than control value.
According to CD analysis, native insulin exhibited two min-
ima at 208 nm and 222 nm, which were replaced by a single
minimum at 216 nm with the progress of incubation at 50‡C
(Fig. 3A). This observation is in agreement with the report by
Bouchard et al. [29]. The CD spectra for insulin solution
containing betaine and trehalose showed a single minimum
between 208 and 216 nm indicating decreased amyloid forma-
tion in the presence of these solutes (Fig. 3A). Trehalose
showed a greater inhibitory e¡ect compared to betaine with
CD spectrum closer to that of native insulin. The CD spectra
of trehalose (Fig. 3B) show that higher amounts of native
insulin were present with increased trehalose concentrations
as indicated by higher values of negative ellipticity at 208
nm. In case of ectoine and citrulline, their own interference
with insulin CD spectra could not be removed even with dial-
ysis treatment (data not shown).
Amyloid ¢bril formation is known to occur through nucle-
ation and elongation as intermediate steps [30]. In this work,
in order to ¢gure out which of these two stages is actually the
point of inhibition by small stress molecules, insulin amyloid
formation was carried out in the presence of pre-incubated
solution (1% v/v). Addition of the pre-incubated solution
could supply amyloid seed/nuclei to the fresh insulin solution,
thereby leaving only the elongation stage for inhibitor action
by small stress molecules. In seeded solution, insulin amyloid
formation occurred with negligible lag phase (Fig. 4). Accord-
ing to the ThT £uorescence pro¢les, inhibitory e¡ects by tre-
halose, betaine, and citrulline were signi¢cantly reduced in the
presence of seeds except for ectoine. The decreased inhibitory
e¡ect was also con¢rmed by AFM analysis, where high den-
Fig. 1. E¡ect of small stress molecules on insulin amyloid forma-
tion. Control (F), trehalose (R), betaine (b), ectoine (U) and citrul-
line (a). All stress molecules were at 300 mM concentration. Data
shown are ThT time pro¢les for insulin (1 mg/ml, pH 2) amyloid
formation incubated at 50‡C. Error bar represents the standard de-
viation in triplicate measurements.
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sity insulin ¢brils were observed even with the small solutes
(data not shown). This result suggests that the inhibitory ef-
fect of trehalose, betaine, and citrulline is partially nucleation-
speci¢c, whereby formation of amyloid oligomers or nuclei is
prevented.
The observed phenomenon was hypothesized to be the
combined e¡ect of increased surface tension of solution
coupled with preferential hydration of insulin monomers by
the presence of small stress molecules. Small stress molecules
were reported to increase the surface tension of aqueous so-
lutions, while they were preferentially excluded from the vi-
cinity of protein monomers making the proteins hydrated with
solvent molecules [23]. Unfolding of protein monomers in-
creases the surface area available to protein^solvent interac-
tion [35,36]. This process becomes energetically unfavorable in
the presence of small stress molecules due to the positive free
energy change caused by the increased surface tension of so-
lution. Thus, according to our hypothesis, preferential hydra-
tion in conjunction with increased surface tension forces in-
sulin monomers to retain a compact con¢guration in order to
minimize energy of solvent^protein interaction. This mecha-
nism works against hydrophobic interaction of partially un-
folded insulin monomers, one of the major driving forces for
amyloid formation [30,37,38]. The amyloid formation process
is believed not to be dependent on ‘speci¢c’ protein^solvent
pairs [36], thereby increasing the chances of e⁄cacy of small
stress molecules against ¢brillization of other amyloidogenic
proteins. Further veri¢cation of this proposed mechanism is
awaited. It is noteworthy that molecular chaperones have
been reported to possess functional similarity to the small
stress molecules by restoring native protein structure with
their action against hydrophobic interactions [39]. Heat shock
Fig. 2. AFM images of samples incubated with small stress molecules. A: Control. B: Maltose. C: Trehalose. D: Betaine. E: Ectoine. F: Cit-
rulline. All the small stress molecules were at 300 mM. The images were taken at saturation phase in tapping mode. Scale bar represents 500
nm.
Table 1
Dependence of apparent rate constant (kapp) of amyloid formation on the concentration of small stress molecules
Solute concentration (M) kapp observed in the presence of solute (h31)a
Ectoine Citrulline Betaine Trehalose
0.05 0.64 0.96 1.29 1.27
0.10 0.88 0.94 1.98 1.57
0.20 0.84 0.44 1.29 0.68
0.30 ndb ndb 1.50 0.67
aIn the absence of solute, kapp was found to be 2.47 h31.
bNot determined due to negligible increase of ThT £uorescence for the time period up to 45 h.
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proteins such as sHsp27 and Hsp70 suppressed AL1^42 amy-
loid formation and K-synuclein toxicity, respectively [40,41].
In this work, small stress molecules, i.e. ectoine, betaine,
trehalose, and citrulline, were found to inhibit insulin amyloid
formation. Previous works in the literature prove that the
stress molecules interact with and stabilize the hydrophilic
groups on protein moieties by solvent hydration while the
hydrophobic groups remain on the inside of proteins. This
stabilization process works well against insulin amyloid for-
mation driven by hydrophobic interactions between partially
unfolded protein monomers. The probability of success of
small stress molecules against amyloid formation is further
strengthened by a recent report on the e⁄cacy of trehalose
against Huntington disease [42], which was published at the
time of submitting this article. According to the report, tre-
halose suppressed the formation of polyglutamine aggregates
with strongest inhibitory e¡ect among various disaccharides
when administered orally as a 2% solution to transgenic mice.
The current work, supported by [42], hints at the e⁄cacy of
small stress molecules as lead compounds for designing inhib-
itors against amyloid formation associated with neurodegen-
erative disorders.
Fig. 3. Near-UV CD spectra for insulin amyloid inhibition in the presence of small stress molecules. A: E¡ect of trehalose and betaine (300
mM) on insulin amyloid formation. B: Concentration-dependent inhibitory e¡ect of trehalose on amyloid formation. All spectra were measured
at saturation phase at ambient temperature.
Fig. 4. E¡ect of small stress molecules on amyloid formation in in-
sulin solution that contains amyloid seeds (1% v/v). Control (F), tre-
halose (R), betaine (b), ectoine (U) and citrulline (a). The amyloid
seeds were prepared by pre-incubation for 18 h. Final concentra-
tions of insulin and stress molecules in each vial were the same as
in Fig. 1.
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